DCGI approves Hetero’s Tocilizumab for emergency use against Covid-19
The Drugs Controller General of India (DCGI) has approved emergency use of drug firm Hetero’s Tocilizumab for treatment of hospitalised adults suffering from Covid-19, said Hetero in a statement. Hetero’s statement added that medical practitioners would be able to use the drug for treating Covid-19 in adults who…